Akums Patents Formulation for Sickle Cell Disease Management
September 13, 2024 17:22
Akums Drugs and Pharmaceuticals secures patent for a room temperature stable oral suspension of Hydroxyurea, a cost-effective treatment for Sickle Cell Disease (SCD) in India and worldwide.